Scale-up approach for the preparation of magnetic ferrite nanocubes and other shapes with benchmark performance for magnetic hyperthermia applications
Magnetic nanoparticles are increasingly used in medical applications, including cancer
treatment by magnetic hyperthermia. This protocol describes a solvothermal-based process to …
treatment by magnetic hyperthermia. This protocol describes a solvothermal-based process to …
Generalized myasthenia gravis: classification, clinical presentation, natural history, and epidemiology
MK Hehir, NJ Silvestri - Neurologic clinics, 2018 - neurologic.theclinics.com
Myasthenia gravis (MG) is the most common disorder of the neuromuscular junction. It is the
prototypic autoimmune disease most commonly caused by antibodies to the acetylcholine …
prototypic autoimmune disease most commonly caused by antibodies to the acetylcholine …
Treatment-refractory myasthenia gravis
NJ Silvestri, GI Wolfe - Journal of clinical neuromuscular disease, 2014 - journals.lww.com
Myasthenia gravis (MG) is the most common disorder of neuromuscular transmission and is
a prototypical autoimmune disorder. Most patients with MG are successfully treated with …
a prototypical autoimmune disorder. Most patients with MG are successfully treated with …
The second data release of the sloan digital sky survey
…, K Shimasaku, WA Siegmund, NM Silvestri… - The Astronomical …, 2004 - iopscience.iop.org
The Sloan Digital Sky Survey (SDSS) has validated and made publicly available its Second
Data Release. This data release consists of 3324 deg 2 of five-band (ugriz) imaging data …
Data Release. This data release consists of 3324 deg 2 of five-band (ugriz) imaging data …
The first data release of the sloan digital sky survey
…, K Shimasaku, WA Siegmund, NM Silvestri… - The Astronomical …, 2003 - iopscience.iop.org
The Sloan Digital Sky Survey (SDSS) has validated and made publicly available its First
Data Release. This consists of 2099 deg 2 of five-band (u, g, r, i, z) imaging data, 186,240 …
Data Release. This consists of 2099 deg 2 of five-band (u, g, r, i, z) imaging data, 186,240 …
The third data release of the sloan digital sky survey
…, E Sheldon, K Shimasaku, NM Silvestri… - The Astronomical …, 2005 - iopscience.iop.org
This paper describes the Third Data Release of the Sloan Digital Sky Survey (SDSS). This
release, containing data taken up through 2003 June, includes imaging data in five bands …
release, containing data taken up through 2003 June, includes imaging data in five bands …
A catalog of spectroscopically confirmed white dwarfs from the Sloan digital sky survey data release 4
…, SJ Kleinman, A Nitta, N Silvestri… - The Astrophysical …, 2006 - iopscience.iop.org
… We flag stars that had reduced 2 greater than 1.5, or signal-to-noise ratio (S/N) less than 2
per spectroscopic pixel, or two or fewer bands of good photometry. We also flag stars with S/N …
per spectroscopic pixel, or two or fewer bands of good photometry. We also flag stars with S/N …
Spectroscopic properties of cool stars in the Sloan Digital Sky Survey: an analysis of magnetic activity and a search for subdwarfs
…, LM Walkowicz, KR Covey, NM Silvestri… - The Astronomical …, 2004 - iopscience.iop.org
We present a spectroscopic analysis of nearly 8000 late-type dwarfs in the Sloan Digital Sky
Survey. Using the Hα emission line as an activity indicator, we investigate the fraction of …
Survey. Using the Hα emission line as an activity indicator, we investigate the fraction of …
A catalog of spectroscopically identified white dwarf stars in the first data release of the Sloan digital sky survey
…, JR Pier, G Schmidt, NM Silvestri… - The Astrophysical …, 2004 - iopscience.iop.org
We present the full spectroscopic white dwarf and hot subdwarf sample from the Sloan Digital
Sky Survey (SDSS) first data release, DR1. We find 2551 white dwarf stars of various types…
Sky Survey (SDSS) first data release, DR1. We find 2551 white dwarf stars of various types…
Rituximab as treatment for anti-MuSK myasthenia gravis: multicenter blinded prospective review
…, LD Hobson-Webb, M Benatar, C Barnett, NJ Silvestri… - Neurology, 2017 - AAN Enterprises
… similar between the rituximab-treated patients (n = 24) and the controls (n = 31). Median
follow-up … N. Silvestri has consulted for Alexion and OptionCare for unrelated myasthenia gravis …
follow-up … N. Silvestri has consulted for Alexion and OptionCare for unrelated myasthenia gravis …
